Soleno Therapeutics (SLNO) is down -29.0%, or -$18.49 to $45.36.
Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on SLNO:
- Soleno Therapeutics falls -26.7%
- Soleno Therapeutics price target lowered to $106 from $123 at Wells Fargo
- Soleno Therapeutics Achieves Profitability with VYKAT XR Launch
- Soleno Therapeutics: Strong Sales Growth and Profitability Drive Buy Rating
- Closing Bell Movers: AMD falls 4% on earnings, Trex, Pinterest down sharply